A new trading day began on Tuesday, with Cabaletta Bio Inc (NASDAQ: CABA) stock price down -6.70% from the previous day of trading, before settling in for the closing price of $1.79. CABA’s price has ranged from $1.59 to $19.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -41.45%. With a float of $44.47 million, this company’s outstanding shares have now reached $48.85 million.
The extent of productivity of a business whose workforce counts for 103 workers is very important to gauge. In terms of profitability, gross margin is 71.2%, operating margin of -2855.41%, and the pretax margin is -2597.61%.
Cabaletta Bio Inc (CABA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Cabaletta Bio Inc is 9.03%, while institutional ownership is 74.15%.
Cabaletta Bio Inc (CABA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -41.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -17.19% during the next five years compared to -26.63% drop over the previous five years of trading.
Cabaletta Bio Inc (NASDAQ: CABA) Trading Performance Indicators
Here are Cabaletta Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.16, a number that is poised to hit -0.63 in the next quarter and is forecasted to reach -2.55 in one year’s time.
Technical Analysis of Cabaletta Bio Inc (CABA)
The latest stats from [Cabaletta Bio Inc, CABA] show that its last 5-days average volume of 0.83 million was inferior to 1.24 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 30.32%. Additionally, its Average True Range was 0.18.
During the past 100 days, Cabaletta Bio Inc’s (CABA) raw stochastic average was set at 2.07%, which indicates a significant decrease from 19.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.57% in the past 14 days, which was lower than the 121.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.2146, while its 200-day Moving Average is $4.5523. Now, the first resistance to watch is $1.7600. This is followed by the second major resistance level at $1.8500. The third major resistance level sits at $1.9000. If the price goes on to break the first support level at $1.6200, it is likely to go to the next support level at $1.5700. Assuming the price breaks the second support level, the third support level stands at $1.4800.
Cabaletta Bio Inc (NASDAQ: CABA) Key Stats
With a market capitalization of 81.62 million, the company has a total of 48,877K Shares Outstanding. Currently, annual sales are 0 K while annual income is -67,680 K. The company’s previous quarter sales were 0 K while its latest quarter income was -30,630 K.
